SPORE in Gastrointestinal Cancer

Project: Research project

Description

DESCRIPTION (provided by applicant)
The American Cancer Society estimates that over 170,000 US citizens will
develop gastrointestinal (GI) cancer this year; 100,000 will die. Led by
cancers of the colon, esophagus and pancreas, GI cancers account for over 17
percent of US cancer deaths. The goal of this interdisciplinary Specialized
Program of Research Excellence (SPORE) in GI Cancer at the Arizona Cancer
Center (ACC) is to prevent and cure GI cancers. The SPORE will approach this
goal through studies in prevention, genetics and therapeutics. In particular,
the SPORE will attack the poor survivability linked to delayed detection.
StatusFinished
Effective start/end date9/5/023/31/15

Funding

  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health

Fingerprint

Gastrointestinal Neoplasms
Research
G-Quadruplexes
Drug Delivery Systems
Neoplasms
Pancreatic Neoplasms
Esophagus
Biometry
Colon
Research Personnel
Organized Financing
Transcriptional Silencer Elements
Pharmaceutical Preparations
Computer-Aided Design
United States Department of Veterans Affairs
Clinical Trials, Phase I
Drug Design
DNA
Clinical Trials
Therapeutics

ASJC

  • Medicine(all)